CONRAD 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
elvitegravir/tenofovir alafenamide insert (TAF/EVG insert) / CONRAD, National Institute of Allergy and Infectious Diseases
RITE PrEP, NCT06274398: Rectal Insert TAF/EVG Pre-Exposure Prophylaxis () Study

Recruiting
1
24
US
TAF/EVG rectal insert, Matching placebo rectal insert
Eastern Virginia Medical School, CONRAD, Emory University, Centers for Disease Control and Prevention
Safety Issues
10/24
12/24
tenofovir alafenamide/elvitegravir vaginal insert (TAF/EVG vaginal insert) / CONRAD
NCT06087913: Safety and PK Multi-dose Study of TAF/EVG Vaginal Insert

Recruiting
1
60
US, RoW
TAF/EVG vaginal insert, Matching Placebo vaginal insert
Eastern Virginia Medical School, CONRAD, University of Pittsburgh, Centre for the AIDS Programme of Research in South Africa, Kenya Medical Research Institute, United States Agency for International Development (USAID)
Safety Issues
10/24
06/25
levonorgestrel butanoate (HRP002) / NICHD Neonatal Research Network, CONRAD
NCT04143659: A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception

Recruiting
1
136
US
levonorgestrel butanoate (LB) injection
Health Decisions, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Healthy Women, Female Contraception
09/24
09/24
tenofovir vaginal gel (GS-1278 gel) / Gilead, CONRAD
NCT01645813: Trial to Assess the Implementation Effectiveness and Safety of 1% Tenofovir Gel Provision

Not yet recruiting
1
700
NA
1% TFV Gel - Public Sector Clinic, 1% TFV Gel - CAPRISA research clinics
CONRAD
HIV
03/15
 

Download Options